BioCentury
ARTICLE | Strategy

Found in translation: Institute Pasteur Korea

August 22, 2013 7:00 AM UTC

Institute Pasteur Korea, a branch of France's Pasteur Institute primarily financed by the government of South Korea, is starting to see translatable results from its partnering and drug screening efforts. Institute Pasteur Korea recently announced its third deal of the year, licensing a tuberculosis candidate to Qurient Co. Ltd., an institute spinout.1

Qurient plans to start a Phase I trial of the TB compound, Q203, early next year...